Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol with Chemotherapy in Second Line Glioblastoma Multiforme
NCT03861598Phase 1Terminated
- Sponsor
- West Virginia University
- Start
- Jul 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of carvedilol in glioblastoma multiforme (GBM), sponsored by West Virginia University. Primary endpoint: Correlation between RT-qPCR assay for circulating tumor cells and MRI response at Cycle 4. Started Jul 2019; status: terminated.
02
Drugs
carvedilol
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT03861598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03861598.